Not All 30-Gy Regimens Are Equal

Affiliations

Comment

Adam S Garden. J Clin Oncol. 2019.

. 2019 Dec 20;37(36):3558-3559.

doi: 10.1200/JCO.19.01666. Epub 2019 Sep 26.

¹ Adam S. Garden, MD, University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

Comment in

Reply to A.S. Garden.
Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller RC, Shiraishi S, Mutter RW, Corbin KS, Park SS, Foote RL. Ma DJ, et al. J Clin Oncol. 2019 Dec 20;37(36):3559-3560. doi: 10.1200/JCO.19.02144. Epub 2019 Sep 26. J Clin Oncol. 2019. PMID: 31557088 No abstract available.

Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.
Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Foster NR, Ginos B, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Olsen KD, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller R, Shiraishi S, Foote RL. Ma DJ, et al. J Clin Oncol. 2019 Aug 1;37(22):1909-1918. doi: 10.1200/JCO.19.00463. Epub 2019 Jun 4. J Clin Oncol. 2019. PMID: 31163012 Free PMC article. Clinical Trial.